Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon / Breccia, M; Diverio, D; Pane, Fabrizio; Nanni, M; Russo, E; Biondo, F; Frustaci, A; Gentilini, F; Alimena, G.. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - STAMPA. - 30:(2006), pp. 1577-1579.
Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon
PANE, FABRIZIO;
2006
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
